AU Patent

AU2014276856B2 — Stable oral solutions for combined API

Assigned to Pharnext SA · Expires 2018-11-15 · 8y expired

What this patent protects

The present invention relates to a homogeneous, stable, and palatable pharmaceutical solution comprising baclofen, sorbitol and naltrexone.

USPTO Abstract

The present invention relates to a homogeneous, stable, and palatable pharmaceutical solution comprising baclofen, sorbitol and naltrexone.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014276856B2
Jurisdiction
AU
Classification
—
Expires
2018-11-15
Drug substance claim
No
Drug product claim
No
Assignee
Pharnext SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.